Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |